Soluble HLA-G and HLA-E Levels in Bone Marrow Plasma Samples Are Related to Disease Stage in Neuroblastoma Patients

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_center" colspan="2">⁢Age (years)</td><td class="align_center" colspan="2">Sex</td></tr><tr class="thead"><td class="align_center">Range</td><td class="align_center">Mean ± SD</td><td class="align_center">M</td><td class="align_center">F</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_center">20–54</td><td class="align_center">39.6 ± 13</td><td class="align_center">8</td><td class="align_center">5</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Healthy donors’ characteristics. First row indicates all the variables analyzed in healthy controls, second row indicates the subgroups for each variable, and third row indicates the number of subjects in each group.

Journal of Immunology Research

tab2

Table 2

Table 2: Soluble HLA-G and HLA-E Levels in Bone Marrow Plasma Samples Are Related to Disease Stage in Neuroblastoma Patients 